CS Paper Radar

TRACE: Deployable Tree-Relational Structure Enhancement for Oncology LLMs

Jizheng Lai, Yingyun Li, Ying Qin, Haiyang Qian

cs.CL cs.AI ·submitted 2026-09-20 07:37 UTC · v1
top venuebenchmark

Abstract

Large language models are increasingly used in oncology applications, but their predictions are often weakly grounded in explicit medical structure. We present TRACE, a deployable tree-relational enhancement framework for oncology LLMs. TRACE separates expensive offline structure learning from lightweight online inference: oncology concepts and relations are organized into an updatable tree-relational structure, refined using LM-loss-derived evidence, and retrieved at inference time as compact prompt evidence. This design supports task-adaptive evidence selection without requiring supervised labels in the zero-shot setting. Across ten oncology classification tasks and one MedQuAD CancerGov QA benchmark, TRACE improves both label-free evaluation and supervised fine-tuning. Additional analyses show that TRACE improves over vanilla RAG and generic GraphRAG, remains useful under leakage-controlled METABRIC inputs, and produces interpretable evidence paths aligned with clinical reasoning. These results suggest that explicit, updatable medical structure is a practical path toward more accurate and auditable oncology LLM deployment.

Comment
18 pages, 2 figures, 19 tables. Accepted to the EMNLP 2026 Industry Track for oral presentation

Closest papers

Nearest neighbours by meaning across the whole index.

Dense Clinical Contrasts Enhance Medical Knowledge Updating in Large Language Models

cs.AI ·2026-08-31 ·Yangmin Huang, Shu Quan, He Geng, Xin Ye, Qianyun Du +3 more
top venuebenchmark similarity 0.67
Abstract · Accepted to Findings of EMNLP 2026

Medical knowledge changes continually, making large language models vulnerable to relying on outdated yet clinically plausible information. We study whether the format of supervision affects medical knowledge updating under a matched training-budget setting. We introduce SEER-Bench, a temporally anchored oncology-staging benchmark curated from the latest versioned SEER Research Data release, and render identical medical update events from NCCN oncology guidelines into four supervision formats: EMQ, MSQ, FITB, and SAQ. Across SEER-Bench and HealthBench Professional, EMQ gives the most stable external transfer and retention among same-budget SFT variants. With EMQ supervision, the updated 4B model produces competitive results on temporally anchored oncology staging, reaching 64.8% answer accuracy and 59.6% rationale accuracy on SEER-Bench. Diagnostic analyses suggest that EMQ exposes denser clinical contrast signals while preserving discriminative representations with smaller movement from the base model. These results show that medical knowledge updating depends not only on the update algorithm, but also on how knowledge is structured as supervision.

0.37

Tool-Augmented On-Policy Distillation for LLM Domain Adaptation in Sequence-Based Omics Tasks

cs.LG cs.CL ·2026-09-20 ·Jie Ying, Zhefan Wang, Zihong Chen, Zhengqing Li, Jinzhe Li +9 more
benchmark similarity 0.65
Abstract · 18 pages, 5 figures

Multi-omics sequences contain complex biological patterns, yet deciphering their mechanisms for automated scientific discovery remains challenging. As large language models (LLMs) interpret these sequences, evaluating both predictions and scientific reasoning is critical. However, existing benchmarks for multi-omics sequence tasks rely on classification and regression metrics, neglecting whether models grasp the underlying biological evidence. We introduce OmicsBench, the first reasoning benchmark for multi-omics sequences, comprising 1,160 expert-validated questions across six tasks spanning DNA regulation, RNA processing, and protein function. OmicsBench requires traceable evidence chains, evaluated using instance-specific rubrics developed with domain experts. Evaluating 17 LLMs reveals an inverse relationship: while scientific LLMs outperform general-purpose LLMs in sequence classification accuracy, they fail to provide valid evidence to support their predictions. One plausible interpretation is shortcut learning: specialized models may rely on statistical patterns rather than the biological mechanisms needed for scientific discovery. Motivated by this finding, we introduce tool-augmented on-policy distillation (TA-OPD), a post-training method to align sequence prediction with evidence-grounded biological reasoning. Across five Qwen3.5 models spanning 0.8B to 27B parameters, TA-OPD consistently strengthens biological evidence grounding while improving predictive performance on most tasks. These gains persist across model scales, indicating that stronger sequence reasoning does not arise solely from increased model capacity, but can be improved through evidence-aware training. Together, OmicsBench and TA-OPD provide a framework for diagnosing reasoning failures in multi-omics LLMs and a path toward models whose predictions are better grounded in biologically meaningful evidence.

0.14

OpenMTB-Audit: Exposing Over-Refusal and Clinical Expert Perspectives in LLM-Based Molecular Tumor Board Safety Evaluation

cs.AI cs.LG ·2026-10-01 ·Negin Ashrafi, Jia Luo, Stacey M. Frumm, Roxana Daneshjou
publishedbenchmarkcode/data similarity 0.65
Abstract · Accepted for oral presentation and publication at the Pacific Symposium on Biocomputing (PSB) 2027

Molecular tumor boards integrate genomic findings, clinical context, and therapeutic evidence to support precision oncology. As AI enters this workflow, a key safety challenge is distinguishing truly unsupported recommendations from evidence-supported options that still require oncologist review because of incomplete information, poor ECOG performance status, or other clinical caveats. We introduce OpenMTB-Audit, an open-source benchmark of 500 synthetic non-small cell lung cancer cases spanning five adversarial error categories and four safety labels: Supported, Partially Supported, Unsupported, and Insufficient Information. Across eight large language model configurations, we identify pervasive over-refusal: all LLM configurations failed to retain the Partially Supported label in 83.3-100% of true Partially Supported cases, achieving high aggregate safety scores through label collapse rather than clinically calibrated reasoning. To address this limitation, we developed MTB-AuditAgent, a deterministic seven-module framework separating evidence verification, missing-information detection, safety classification, and abstention. It reduces over-refusal to 6.7% and achieves 91.2% accuracy (95% CI: 88.6-93.6%). A two-oncologist annotation study found disagreement concentrated at the boundary between information sufficiency and treatment optimization, underscoring the need to preserve clinically meaningful distinctions.

0.56

Cite What You Explore: Budget-Aware LLM Reasoning over Medical KGs with Verifiable Evidence

cs.LG ·2026-10-06 ·Chen Chen, Dongjie Wang, Mei Liu, Zijun Yao
top venuebenchmarkcode/data similarity 0.64
Abstract · Accepted to NeurIPS 2026. This revision corrects cohort statistics and efficiency reporting, removes incorrectly reported per-disease standa…

Post-discharge risk prediction from electronic health records (EHRs) is difficult because many dependencies that link discharge-time observations to downstream complications, such as comorbidity cascades and drug-disease interactions, are absent from the record. External medical knowledge graphs (KGs) can supply these missing dependencies, but tracing them in a clinical setting demands three properties. KG exploration must remain cost-bounded, retrieved evidence must be differentiated by source quality, and the resulting rationale must be citable for review. Large language models (LLMs) can plan and verify over structured evidence, making them natural candidates for KG reasoning, but existing LLM-based methods do not satisfy these three properties jointly. In this paper, we propose BAR, a Budget-Aware LLM Reasoning framework over medical KGs with three contributions. First, BAR refines the raw KG into disease-specific evidence graphs whose edges carry support scores and provenance records, turning the KG into a quality-annotated reasoning space rather than a static feature source. Second, an LLM reasons over this graph through a plan-navigate-verify loop that decomposes the question into steps, retrieves evidence under a patient-specific budget, and revises when verification fails. Third, a reasoning policy is trained with a reward that compares predictions with and without acquired evidence, combined with acquisition cost and citation-integrity terms. Across 8 diseases and 3 prediction horizons on MIMIC-III and MIMIC-IV, BAR achieves higher performance and citation precision than strong baselines while using fewer LLM tokens. Its gain over EHR-only prediction grows at longer horizons, and its advantage carries over to an external benchmark.

0.36

SentryLine: Evidence-Grounded Question Answering over Evolving Documents in Oncology Care

cs.CL ·2026-09-08 ·Tampu Ravi Kumar, Gaurav Najpande, Muhammad Ali Khan, Kaneez Zahra Rubab Khakwani, Karan Kathuria +5 more
top venuebenchmark similarity 0.64
Abstract

Oncology care operates at constant pressure of absorbing rapidly evolving evidence base in biomedicine. The American Society of Clinical Oncology (ASCO) addresses this through living guidelines, but the format introduces a new burden: any recommendation can change at any point, across multiple versioned documents. We present SENTRYLINE, a living guideline-aware clinical question answering system. SENTRYLINE retrieves guideline passages through a vectorless hierarchical RAG pipeline and returns a role-specific answer with inline citations, factual and temporal verification reports, and drift detection notes that surface when a guideline has been updated. We construct ASCOBENCH, a benchmark of 405 three-turn conversations across four question categories with gold answers from expert annotators(clinicians), and use test set to evaluate SENTRYLINE against five baselines under an LLM-as-judge framework. Experiments across three generation backbones show consistent improvements over four retrieval baselines and ASCO's guideline assistant, with particularly strong gains on Reasoning and Role-Specific questions where multi-hop synthesis and register adaptation are required

0.69

ChestPheNoT: Deployable, Auditable Label-Status-Evidence Extraction from Radiology Reports

cs.CL cs.AIcs.LG ·2026-09-09 ·Kai Yu, Chenyu Zhu, Zaifu Zhan, Meijia Song, Min Zeng +3 more
publishedcode/data similarity 0.64
Abstract · Accepted at IEEE Healthcom 2026

Structured phenotype extraction from radiology reports supports cohort construction, quality auditing, and clinical analytics, but practical deployment requires local inference and auditable predictions, while expert annotations remain scarce. Conventional labelers provide structured findings and assertion states but no supporting evidence, while API-hosted large language models may be unsuitable when clinical text cannot leave institutional infrastructure. We present CHESTPHENOT, a compact 0.5-3B language model that jointly extracts finding labels, three-class status (present/absent/uncertain), and verbatim supporting evidence spans. CHESTPHENOT is trained using hybrid CheXbert+72B silver supervision followed by supervised fine-tuning and lightweight GRPO refinement. Across three human-annotated gold sets spanning in-distribution, cross-taxonomy, and cross-institution evaluation, the 3B model remains below its CheXbert silver teacher in distribution but is competitive under distribution shift, significantly surpassing CheXbert on cross-institution detection (+2.0 F1). Task-specific training also enables the 3B model to match or exceed substantially larger prompted models on most detection and status comparisons. For evidence-grounded extraction, over 99% of final evidence spans are locatable in the source report, and the 3B model achieves 47.5 auditable-F1, outperforming Qwen2.5-7B one-shot prompting by 7.6 points and approaching Qwen2.5-72B. These results demonstrate that locally deployable models can provide competitive and directly auditable radiology-report extraction without relying on external inference APIs. Code and the full extraction/judge prompts will be made available at https://github.com/yukkai/ChestPheNoT.

0.43

OpenTumorBoard: A Real-World Benchmark of Multidisciplinary Tumor Board Discussion Trajectories

cs.CL cs.LG ·2026-09-26 ·Anqi Li, Zhixuan Ge, Yixuan Duan, Jiarong Qian, Chi-Yu Chen +7 more
benchmark similarity 0.63
Abstract · Preprint. Includes supplementary material. Added dataset and leaderboard links

Multidisciplinary tumor boards integrate multimodal clinical observations and longitudinal patient histories through specialist discussions, yet benchmarks rarely capture these real-world trajectories. We introduce OpenTumorBoard, a benchmark with 611 patient cases and 19,157 discussion turns across ten specialist roles, transcribed from 12,534 minutes of publicly available tumor board recordings on YouTube. The benchmark evaluates two settings: SPECIALIST TURN, in which an LLM responds to a clinically significant question posed during a real discussion, and BOARD SIMULATION, in which it generates an entire back-and-forth discussion and reaches a consensus on therapy recommendations, surgical plans, next actions and clinical trial matching. Evaluation of 14 general-purpose frontier and medical LLMs reveals substantial limitations: the best models score 3.43 out of 5 in clinical equivalence to specialist answers and 2.78 out of 5 in alignment with recorded board conclusions. Supervised finetuning and reinforcement learning improve performance on a held-out test set, suggesting that real-world discussion trajectories can support model adaptation. Three M.D. experts review a subset of the benchmark, finding high information coverage and factuality of patient cases and strong fidelity of extracted consensus conclusions. We will release OpenTumorBoard and its automated curation pipeline to support the development and evaluation of LLMs for multidisciplinary, personalized cancer decision-making.

0.21

DiagTrace: An Interactive Benchmark for Clinical Decision Making

cs.CL cs.AI ·2026-11-16 ·Yufan Wang, Rui Yang, Yi Lin, Chunhua Weng, Yifan Peng
publishedbenchmark similarity 0.63
Abstract · Accepted to Findings of EACL 2027

Large language models (LLMs) have shown strong performance on medical question answering and diagnostic reasoning benchmarks. However, existing evaluations typically provide all patient information upfront and assess only the final diagnosis or rationale. This setup ignores the need to acquire diagnostic evidence incrementally from incomplete information in real-world diagnosis. To bridge this gap, we introduce DiagTrace, a source-grounded benchmark for evaluating whether LLMs can reconstruct the documented diagnostic trajectory through interactive information seeking. Each benchmark instance is built from a PubMed Central case report and includes an initial presentation, an event bank, a clinical course, and diagnostic references. DiagTrace contains 510 cases across eight specialties, with 225 used to evaluate four LLMs on clinical-course alignment, interaction quality, and efficiency. Results reveal trade-offs in coverage, source-consistent ordering, and turn use.

0.14